Biofrontera Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 0.9315 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 13.83M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.